®
®
Neozyme International, Inc. Announces Successful Treatment of Chronic Grease Cap at Municipal Wastewater Treatment Facility in New York City. July 7, 2003 - Neozyme International, Inc. (Neozyme), a subsidiary of International Daleco Corporation (ILDO), is pleased to announce that it has successfully installed a bio-organic catalyst spray system that eliminates the chronic grease caps that form in wastewater treatment plants. This installation has demonstrated the superior capabilities of Neozyme’s fats, oils, and greases (FOG) bio-organic catalyst formulation, Eco-Zyme™, in treating this common maintenance problem that most wastewater treatment facilities must now remove with expensive pump outs. The accumulation of grease caps and clogging of FOG’s in pipes is endemic throughout the municipal wastewater treatment industry.
Neozyme’s New York distributor, R. B. Bender & Associates, having successfully introduced this application of the Company’s proprietary bio-organic catalyst, is now actively pursuing a number of additional installations within the New York City municipal wastewater treatment facility system, as well as within the broader regional marketplace. Additionally, Neozyme is expanding its FOG expertise into Pennsylvania and elsewhere through its marketing development advisor, Solid Thinking, Inc., who is working with the Company to develop a comprehensive marketing program.
Neozyme manufactures and sells its patented line of bio-organic catalytic formulations for numerous markets including, but not limited to, municipal wastewater treatment, commercial/industrial, hydrocarbon remediation, industrial metal cleaning and agriculture. All Neozyme products are non-toxic, 100% biodegradable and can be safely used around humans, animals, marine life, vegetation and the environment. No special clothing or handling apparatus is required. For more information, please visit www.Neozyme.com.
This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company’s expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company’s control. Therefore, actual results could differ materially from the forward-looking statements herein.
Home|SiteMap|Company|FAQs|Technology|Applications|Products|Connect|News|Links